Daniel Loeb’s Merck MRK Stock Holding History

Daniel Loeb’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,908,200	Closed	-$212M	–	34
2018 Q4	$212M	Sell	2,908,200 -1,807,800	-38%	-$128M	3.26%	10
2018 Q3	$319M	Buy	+4,716,000	New	+$300M	2.23%	15

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Daniel Loeb's MRK Position: Q1 2019 in Review

Daniel Loeb sold out of Merck (MRK) in Q1 2019, closing a stake of 2,908,200 shares — an estimated $212M sold.

Daniel Loeb first reported a position in MRK in Q3 2018 and held it in 2 quarters. The position peaked at $319M in Q3 2018. 2,293 funds tracked by Wall St. Rank hold MRK as of Q1 2019.

Daniel Loeb reported no remaining Merck position as of Q1 2019 after selling out during the quarter.
Daniel Loeb sold 2,908,200 Merck shares in Q1 2019, an estimated $212M.
Daniel Loeb first reported a position in Merck in Q3 2018 and held it in 2 quarters.
Daniel Loeb's Merck position peaked at $319M in Q3 2018.
2,293 funds tracked by Wall St. Rank held Merck as of Q1 2019.

Based on Third Point's 13F filing for Q1 2019, filed 15 May 2019.